Sultan Linjawi

1.0k total citations
11 papers, 613 citations indexed

About

Sultan Linjawi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sultan Linjawi has authored 11 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Sultan Linjawi's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (5 papers). Sultan Linjawi is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (5 papers). Sultan Linjawi collaborates with scholars based in Australia, Denmark and United States. Sultan Linjawi's co-authors include Bruce W. Bode, Helena W. Rodbard, Vincent Woo, John B. Buse, Stephen Gough, Pernille Poulsen, Yehuda Handelsman, Louis Chaykin, J.P. Courrèges and Julia Lowe and has published in prestigious journals such as Drugs, The Lancet Diabetes & Endocrinology and Diabetes Obesity and Metabolism.

In The Last Decade

Sultan Linjawi

11 papers receiving 586 citations

Peers

Countries citing papers authored by Sultan Linjawi

Since Specialization

Citations

This map shows the geographic impact of Sultan Linjawi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sultan Linjawi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sultan Linjawi more than expected).

Fields of papers citing papers by Sultan Linjawi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sultan Linjawi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sultan Linjawi. The network helps show where Sultan Linjawi may publish in the future.

Co-authorship network of co-authors of Sultan Linjawi

This figure shows the co-authorship network connecting the top 25 collaborators of Sultan Linjawi. A scholar is included among the top collaborators of Sultan Linjawi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sultan Linjawi. Sultan Linjawi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes 2020 ·Drugs ·Stewart B. Harris, Martin J. Abrahamson, Antonio Ceriello, G. Charpentier, Marc Evans, Roger Lehmann, Andreas Liebl, Sultan Linjawi, Richard I. G. Holt, Nóra Hosszúfalusi, Guy E.H.M. Rutten, Tina Vilsbøll	17
2	15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes 2018 ·Drugs in R&D ·(unknown), Viswanathan Mohan, Wenying Yang, Krzysztof Strojek, Sultan Linjawi	5
3	Efficacy and Safety of Ideglira in Older Patients with Type 2 Diabetes 2018 ·Endocrine Practice ·Ildiko Lingvay, Yehuda Handelsman, Sultan Linjawi, Tina Vilsbøll, Natalie Halladin, (unknown), Andreas Liebl	10
4	A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes 2017 ·Diabetes Therapy ·Sultan Linjawi, Byung‐Wan Lee, Ömür Tabak, (unknown), (unknown), (unknown)	6
5	The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial 2016 ·Diabetes Therapy ·Sultan Linjawi, Bruce W. Bode, Louis Chaykin, J.P. Courrèges, Yehuda Handelsman, Lucine Lehmann, Abhishek Mishra, Richard W Simpson	103
6	One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial 2015 ·Diabetes Obesity and Metabolism ·Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, M. Zacho, (unknown), John B. Buse	99
7	IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test 2015 ·Journal of Diabetes Science and Technology ·Jens J. Holst, John B. Buse, Helena W. Rodbard, Sultan Linjawi, Vincent Woo, Trine Welløv Boesgaard, Kajsa Kvist, Stephen Gough	20
8	The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin—The Sit2Mix trial 2014 ·Primary care diabetes ·Sultan Linjawi, (unknown), Ramazan Sarı, Henning Andersen, (unknown), Paturi Vishnupriya Rao	12
9	Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes 2014 ·The Lancet Diabetes & Endocrinology ·Stephen Gough, Bruce W. Bode, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, Pernille Poulsen, (unknown), John B. Buse	265
10	1.1 IDegLira, a Novel Fixed Ratio Combination of Insulin Degludec and Liraglutide, is Efficacious and Safe in Subjects with Type 2 Diabetes: A Large, Randomized Phase 3 Trial (65-OR) 2013 ·John B. Buse, Stephen Gough, Vincent Woo, Helena W. Rodbard, Sultan Linjawi, Pernille Poulsen, (unknown), Bruce W. Bode	11
11	Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course 2008 ·Diabetes Research and Clinical Practice ·Julia Lowe, Sultan Linjawi, M. Mensch, (unknown), John Attia	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact